When taken together, the identification of GSN and PRDX4 proteins associated with LNM in CRC may not only be used as novel biomarkers for the early prognosis of CRC metastasis but also act as promising targets for the treatment of cancer growth, migration, and invasion. This evidence concerns the gene PRDX4 and cancer.